Burjeel Holdings to Revolutionize Cancer Care in MENA with 90% Cheaper CAR-T Therapy
CAR-T therapies, which reprogram a patient's immune cells to attack cancer cells, have shown remarkable success in treating certain blood cancers like leukemia and lymphoma. However, with costs ranging from US$350,000 to over $1 million in global markets, access remains severely restricted. The partnership seeks to dismantle this barrier by enabling the production of CAR-T therapies at a fraction of the current price, making these treatments accessible to a vastly broader patient population in MENA and beyond.
Enhancing Access to Life-Saving Cancer CareThe collaboration will position Burjeel Holdings as a regional hub for advanced cell and gene therapies. By enabling local, point-of-care production of patient-specific therapies, the initiative will expand the reach of these therapies to underserved populations across the MENA region. The first phase of the program will focus on CAR-T therapies for leukemia and lymphoma, with plans to explore treatments for other diseases, including HIV, in the future.
'We are honored to partner with Caring Cross, whose expertise in CAR-T cell therapy production technology will enable us to provide affordable, life-saving treatments to our communities and beyond. This partnership is a pivotal step in our commitment to advancing medical innovation and expanding access to critical healthcare services,' said John Sunil, Group CEO of Burjeel Holdings.
'We are excited to partner with Burjeel Holdings to improve access to CAR-T cell and other ATMPs for patients across their hospital networks in the MENA region,' said Boro Dropulić, Executive Director of Caring Cross. 'This collaboration advances our mission to make these groundbreaking treatments accessible and affordable around the world. By combining our innovative technologies with Burjeel Holdings hospital network and infrastructure, we intend to significantly improve patient access with a sustainable and cost-effective model.'
Building Local Capabilities and Expanding Impact
This initiative reflects Burjeel Holdings' broader mission to expand access to high-quality healthcare in regions that need it most. The partnership will focus on training and developing local healthcare providers, ensuring the sustainable and scalable delivery of CAR-T therapies across MENA, India, and globally. 'Our collaboration is operating at the cutting edge of medical innovation, opening doors to biological therapies not just in MENA, but also in emerging markets like India and other parts of Asia. This is a monumental stride in enhancing access to cancer treatments and addressing the escalating need for advanced healthcare globally,' said Dr. Ajlan Al Zaki, Director of the Hematology Oncology & Cellular Therapy Center at Burjeel Hospital Abu Dhabi.
This partnership reinforces Burjeel Holdings' commitment to transforming the healthcare landscape in MENA and beyond, offering hope and tangible solutions to millions of patients who previously lacked access to life-saving treatments.
© 2000 - 2025 Al Bawaba (www.albawaba.com)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Roya News
2 days ago
- Roya News
Global NGOs criticize 'Israel's' restrictions on Gaza aid in open letter
A growing number of foreign aid organizations say they are being prevented from delivering essential supplies to Gaza due to recently enacted 'Israeli' legislation, according to a joint letter published Thursday and signed by over 100 groups, including Oxfam and Doctors Without Borders. The letter highlights that tensions between 'Israel' and foreign-backed NGOs have long existed, with officials often criticizing the organizations for bias. "Israeli authorities have rejected requests from dozens of NGOs to bring in lifesaving goods, citing that these organisations are 'not authorised to deliver aid'," the joint statement reads. The letter notes that at least 60 such requests were denied in July alone. The new law, approved in March, updates the registration requirements for foreign NGOs working with Palestinians and outlines the conditions under which applications can be denied or a group's registration revoked. Authorities may reject registration if a group is deemed to deny 'Israel's' democratic character or "promotes delegitimisation campaigns" against the country. "Unfortunately, many aid organisations serve as a cover for hostile and sometimes violent activity," 'Israel's' Diaspora Minister Amichai Chikli told Agence France-Presse (AFP). "Organizations that have no connection to hostile or violent activity and no ties to the boycott movement will be granted permission to operate," he added. Aid organizations, however, argue that the law is leaving civilians without critical support. "Our mandate is to save lives, but due to the registration restrictions civilians are being left without the food, medicine and protection they urgently need," said Jolien Veldwijk, director of CARE in the Palestinian territories. Veldwijk noted that CARE has been unable to deliver aid to Gaza since 'Israel' imposed a full blockade in March, despite a partial easing in May. 'Israel' has cited concerns over Hamas diverting aid as a reason for the restrictions. Since May, the government has relied on the controversial US-backed Gaza Humanitarian Foundation (GHF) to manage food distribution. Meanwhile, Gaza's civil defense agency reports ongoing chaos at distribution centers, with thousands of residents scrambling for supplies each day and some injured by gunfire from the Israeli Occupation Forces (IOF).
Saraha News
4 days ago
- Saraha News
Bank ABC announces results for the period ended 30 June 2025: Net profit attributable to shareholders reaches US$ 152 million
saraha news-Bank ABC (Arab Banking Corporation B.S.C.) – Bahrain Bourse Trading Code 'ABC' – today announces its financial results for H1 2025. Bank ABC continued its resilient performance, against a backdrop of continuing global economic uncertainty, with an H1 net profit of US$152 million, a 1% headline growth over the corresponding period last year. Adjusted for foreign exchange translation differences, underlying* net profit grew by a robust 9% year-on-year (YOY), reflecting strong and diversified core business performance, underpinned by well-controlled credit costs. The Group's total assets reached a historic US$48 billion, propelled by a combination of core business momentum, FX movements as well as portfolio management activity. The Group continued to maintain healthy capital and liquidity buffers. During the period, Bank ABC received several prestigious industry awards, including 'MENA Cash Management Bank of the Year' by MEED's MENA Banking Excellence Awards and 'Best Bank for Sustainable Finance' and 'Bahrain's Best Digital Bank' by Euromoney Awards for Excellence. In addition, ila Bank was named 'MENA Retail Bank of the Year' by MEED and 'Bahrain's Best Consumer Digital Bank' by Euromoney. Bank ABC Islamic was also recognized as 'Best Sukuk House in Bahrain' by Euromoney's Islamic Finance Awards. Bank ABC's Group Chairman, H.E. Naji Belgasem remarked, 'The Group delivered strong results in the first half of 2025, particularly given the turbulent geopolitical environment that prevailed during this period. This stands testament to Bank ABC's diversified business model and focused execution of the strategy, which allows it to leverage market opportunities across the Group's international franchise while maintaining focus on balance sheet health. Business pipelines are strong, supporting confidence in revenue momentum and delivery of sustained value for all our shareholders over the remainder of the year.' Detailed summary of the Financial Results is explained below: Q2 2025 Performance Highlights Consolidated net profit attributable to the shareholders of the parent, for Q2 2025 was US$76 million, +1% higher compared to US$75 million reported for the same period last year, on a headline basis. Underlying* growth in net profit, adjusted for FX impact was+5%. Earnings per share for the period was US$0.024, in line with the same period last year. Total comprehensive income attributable to the shareholders of the parent was a positive US$99 million as compared to a negative US$28 million reported during the same period of last year. Q2 2025 benefitted from the strengthening of currencies (in particular BRL) against the US$, as compared to Q2 2024, which was impacted by the devaluation of the BRL against the US$. Total operating income for Q2 2025 was US$340 million, 3% higher compared to US$331 million reported for the same period last year. Underlying* Total Operating Income for Q2 2025 was US$353 million, compared to US$ 331 million for the same period last year, a YoY growth of +7% after adjusting for FX impact. H1 2025 Performance Highlights Consolidated net profit attributable to the shareholders of the parent, for H1 2025 was US$152 million, a growth of 1% compared to US$150 million reported last year. Underlying* growth in net profit, adjusted for FX impact was +9%, driven by a combination of higher average asset volumes and steady cost of credit. Earnings per share for the period was US$0.046, compared to US$0.046 in the same period last year. Total comprehensive income attributable to the shareholders of the parent was a positive US$253 million as compared to a negative US$56 million during the same period last year. H1 2024 was impacted by the devaluation of Egyptian pound and Brazilian Real against the US$. Total operating income for H1 2025 was US$672 million, as compared to US$674 million reported last year. Underlying* Total Operating Income was US$713 million, reflecting a growth of +6% after adjusting for FX impact reflecting broad based growth across almost all the core markets. Balance Sheet Equity attributable to the shareholders of the parent and perpetual instrument holders at the end of the period was US$4,363 million, compared to US$4,207 million reported at the 2024 year-end, after absorbing the impact of dividend payments. Total assets stood at US$48.0 billion at the end of the period, as compared to US$46.3 billion reported at the 2024 year-end, an increase of 4% driven by core business growth in the loan portfolio, FX movements and balance sheet optimization and portfolio management actions. Healthy Capital and Liquidity ratios: Tier 1 Capital ratio at 14.8%, of which CET1 at 13.0%. LCR and NSFR at 177% and 121% Bank ABC is a leading player in the region's banking industry, with a presence in 15 countries across five continents. It provides innovative global wholesale banking solutions in both conventional and Islamic Finance, across Transaction Banking, Project and Structured Finance, Capital Markets, Financial Markets, Real Estate Finance to corporates and financial institutions. It also provides consumer banking services through its network of branches in Jordan, Egypt, Tunisia, Algeria, and through ila Bank, its digital mobile-only bank, in Bahrain and ila banking app in Jordan.The full financial statements and press release are available on the Bahrain Bourse and Bank ABC's website. Bank ABC will host a virtual Investors call to discuss the H1 2025 earnings on 18 August 2025. Further details and the investor presentation are available at
Jordan Times
4 days ago
- Jordan Times
Military aid to Ukraine — Europe gives more, widening gap with US
PARIS — Europe again increased its military aid to Ukraine in May and June, unlike the United States, and is depending increasingly on its defence industry rather than existing weapons stockpiles, the Kiel Institute for the World Economy said Tuesday. Europe, the United Kingdom included, sent or earmarked a total of 80.5 billion euros in military aid between the start of the war in February 2022 and the end of June 2025 against 64.6 billion euros allocated by the United States. The Germany-based Institute's data shows that the overall European military aid had outstripped the United States in the spring for the first time since June 2022. "A significant proportion of the weapons provided no longer comes from stockpiles but is procured directly through the defence industry," the institute said. "This means that Europe now also leads the US in terms of total volume of military aid provided through industry since the start of the war." Taro Nishikawa, a project lead at the research body's Ukraine Support Tracker, said it was "a clear indication of the expanding role of defence manufacturing in military assistance." In May and June, Europe earmarked 10.5 billion euros of military aid to Ukraine: Germany put up a package of five billion euros, followed by Norway with 1.5 billion euros and Belgium with 1.2 billion euros. The Netherlands, the United Kingdom and Denmark each earmarked between 500 and 600 million euros. At least 4.6 billion euros of the European military aid, or 44 percent of the overall amount in May and June, is set to be channelled through procurement contracts, mainly with Europe-based defence firms, notably based in Ukraine, the Kiel Institute said. Over the same period, Washington approved major exports of arms to Ukraine in May but not in the form of military aid under the Kiel Institute's definition because they have to be paid for by Ukraine itself. The United States was the main provider of aid to Ukraine before Donald Trump's return to the White House on January 20, 2025 when he broke with his Democrat predecessor Joe Biden's Ukraine support strategy. US Vice President JD Vance told the conservative news channel Fox News, in an interview broadcast on Sunday, that he believed Washington had now ended its financial support for Ukraine. "But if the Europeans want to step up and actually buy the weapons from American producers, we are okay with that," he said. Trump and his Russian counterpart Vladimir Putin are scheduled to meet in Alaska on Friday to reach, according to the US president, a possible agreement on exchanging territory to bring an end to the war in Ukraine sparked by the Russian invasion more than three years ago.
